Article Information
History
- November 12, 2019.
Article Versions
- You are currently viewing Version 1 of this article (November 12, 2019 - 01:12).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Oncology Research and Early Development, Oncology R&D, AstraZeneca, Boston, Massachusetts, 02451, USA
- 2Department of Electrical Engineering and Computer Science, Christopher S Bond Life Sciences Center, University of Missouri, Columbia, Missouri, 65211, USA
- 3Department of Biostatistics and Data Science, Wake Forest University, Winston-Salem, North Carolina, 27157, USA
- ↵*To whom correspondence should be addressed. Jing Su: Email: jsu{at}wakehealth.edu, Jonathan Dry: Email: jonathan.dry{at}astrazenca.com, Bolan Linghu: Email: bolan.linghu{at}astrazeneca.com